Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$1.27
-19.15%
Mkt Cap $16.51M
Analyst Ratings
Buy
4
Hold
2
Sell
1
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
Implied Upside
+589.4%
Consensus $8.75 vs current $1.27
NASDAQ·Healthcare·Biotechnology
$1.27
-19.15%
Mkt Cap $16.51M
Buy
4
Hold
2
Sell
1
Price Target (8 analysts)
$8.75
Range $3.00 – $13.00
+589.4%
Consensus $8.75 vs current $1.27